Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data
利用日本上市后全病例监测数据对帕博利珠单抗单药治疗非小细胞肺癌进行真实世界数据分析
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2022.100404
Terai, Hideki; Soejima, Kenzo; Shimokawa, Asanao; Horinouchi, Hidehito; Shimizu, Junichi; Hase, Tetsunari; Kanemaru, Ryota; Watanabe, Kana; Ninomiya, Kiichiro; Aragane, Naoko; Yanagitani, Noriko; Sakata, Yoshihiko; Seike, Masahiro; Fujimoto, Daichi; Kasajima, Masashi; Kubo, Akihito; Kusumoto, Sojiro; Oyamada, Yoshitaka; Fujiwara, Keiichi; Mori, Masahide; Hashimoto, Midori; Shingyoji, Masato; Kodani, Masahiro; Sakamoto, Jin; Agatsuma, Toshihiko; Kashiwabara, Kosuke; Inomata, Minehiko; Tachihara, Motoko; Tanaka, Kazuhisa; Hayashihara, Kenji; Koyama, Nobuyuki; Matsui, Kaoru; Minato, Koichi; Jingu, Daisuke; Sakashita, Hiroyuki; Hara, Satoshi; Naito, Tomoyuki; Okada, Asuka; Tanahashi, Masayuki; Sato, Yuki; Asano, Koichiro; Takeda, Takayuki; Nakazawa, Kensuke; Harada, Toshiyuki; Shibata, Kazuhiko; Kato, Tatsuo; Miyaoka, Etsuo; Yoshino, Ichiro; Gemma, Akihiko; Mitsudomi, Tetsuya